L Liu, Q Zhou, Y Xie, L Zuo, F Zhu, J Lu - Virologica Sinica, 2017 - Springer
Herpesviruses are remarkable pathogens that have evolved multiple mechanisms to evade host immunity, ensuring their proliferation and egress. Among these mechanisms …
X Zheng, J Wang, X Zhang, Y Fu… - Immunity …, 2021 - Wiley Online Library
Abstract Introduction N6‐methyladenosine (m6A) is the most prevalent modification that occurs in messenger RNA (mRNA), affecting mRNA splicing, translation, and stability. This …
LL Zuo, J Zhang, LZ Liu, Q Zhou, SJ Du, SY Xin… - Oncogenesis, 2017 - nature.com
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy, which is notorious among head-and-neck cancers with its metastatic feature. Epstein–Barr virus (EBV) infection plays a …
As a ubiquitous human pathogen, the Epstein–Barr virus (EBV) has established lifelong persistent infection in about 95% of the adult population. The EBV infection is associated …
W Dang, P Cao, Q Yan, L Yang, Y Wang, J Yang, S Xin… - Cancer letters, 2021 - Elsevier
Epstein-Barr virus (EBV) is closely related to the development of several malignancies, such as B-cell lymphoma (B-CL), by the mechanism through which these malignancies develop …
L Liu, L Zuo, J Yang, S Xin, J Zhang, J Zhou… - Cancer …, 2019 - Wiley Online Library
Exosomes have emerged as novel vehicles for proteins and other contents in cancer progression. Cyclophilin A (CYPA) is a pivotal member of immunophilin family. Whether …
L Zuo, Y Xie, J Tang, S Xin, L Liu, S Zhang… - … Therapy-Nucleic Acids, 2019 - cell.com
Nasopharyngeal carcinoma (NPC) is an invasive head-and-neck tumor with Epstein-Barr virus (EBV) as an important etiological cause. The EBV oncoprotein Latent membrane …
S Li, L Yang, Y Li, W Yue, S Xin, J Li, S Long… - Microbiology …, 2023 - Am Soc Microbiol
Epstein-Barr virus (EBV) switches between latent and lytic phases in hosts, which is important in the development of related diseases. However, the underlying mechanism of …
C Wang, J Chen, J Li, Z Xu, L Huang… - The Journal of …, 2024 - Am Soc Clin Investig
Adoptive transfer of T cell receptor–engineered T cells (TCR-T) is a promising strategy for immunotherapy against solid tumors. However, the potential of CD4+ T cells in mediating …